Cargando…

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies

BACKGROUND: Muscle-invasive bladder cancer (MIBC) and upper urinary tract urothelial carcinoma (UTUC) are molecularly heterogeneous. Despite chemotherapies, immunotherapies, or anti-fibroblast growth factor receptor (FGFR) treatments, these tumors are still of a poor outcome. Our objective was to de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, Hervé, Béraud, Claire, Cabel, Luc, Fontugne, Jacqueline, Lassalle, Myriam, Krucker, Clémentine, Dufour, Florent, Groeneveld, Clarice S., Dixon, Victoria, Meng, Xiangyu, Kamoun, Aurélie, Chapeaublanc, Elodie, De Reynies, Aurélien, Gamé, Xavier, Rischmann, Pascal, Bieche, Ivan, Masliah-Planchon, Julien, Beaurepere, Romane, Allory, Yves, Lindner, Véronique, Misseri, Yolande, Radvanyi, François, Lluel, Philippe, Bernard-Pierrot, Isabelle, Massfelder, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405192/ https://www.ncbi.nlm.nih.gov/pubmed/36033544 http://dx.doi.org/10.3389/fonc.2022.930731

Ejemplares similares

A new tumorgraft panel to accelerate precision medicine in prostate cancer
por: Béraud, Claire, et al.
Publicado: (2023)

Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
por: Neyret-Kahn, Hélène, et al.
Publicado: (2023)

Donor/recipient origin of lung cancer after lung transplantation by DNA short tandem repeat analysis
por: De Wolf, Julien, et al.
Publicado: (2023)

IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer
por: Neuzillet, Yann, et al.
Publicado: (2017)

An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
por: Mahe, Mélanie, et al.
Publicado: (2018)

An essential role for decorin in bladder cancer invasiveness
por: El Behi, Mohamed, et al.
Publicado: (2013)

Recurrent activating mutations of PPARγ associated with luminal bladder tumors
por: Rochel, Natacha, et al.
Publicado: (2019)

Cellular Senescence in Renal and Urinary Tract Disorders
por: Santin, Yohan, et al.
Publicado: (2020)

TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
por: Dufour, Florent, et al.
Publicado: (2019)

Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers
por: Lebret, Thierry, et al.
Publicado: (2015)

A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
por: Vallot, Céline, et al.
Publicado: (2011)

Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
por: Shi, Ming-Jun, et al.
Publicado: (2020)

Deregulation of Rab and Rab Effector Genes in Bladder Cancer
por: Ho, Joel R., et al.
Publicado: (2012)

Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort
por: Kullmann, Friederike, et al.
Publicado: (2023)

Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial
por: Culine, Stéphane, et al.
Publicado: (2023)

Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer
por: Borcoman, Edith, et al.
Publicado: (2019)

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
por: Kamoun, Aurélie, et al.
Publicado: (2019)

Unusually Aggressive Actinic Keratosis of the Eyelid and Conjunctiva
por: AL-HAGE, Jana, et al.
Publicado: (2023)

Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer
por: Vacher, Sophie, et al.
Publicado: (2020)

Characterization and Validation of a Chronic Model of Cyclophosphamide-Induced Interstitial Cystitis/Bladder Pain Syndrome in Rats
por: Augé, Céline, et al.
Publicado: (2020)

Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance
por: Hescot, Ségolène, et al.
Publicado: (2022)

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial
por: Pfister, Christian, et al.
Publicado: (2020)

PLEKHS1: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer
por: Pignot, Géraldine, et al.
Publicado: (2019)

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2010)

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2010)

Establishment of a large panel of patient-derived preclinical models of human renal cell carcinoma
por: Lang, Hervé, et al.
Publicado: (2016)

De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
por: Morel, Adeline, et al.
Publicado: (2019)

Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity
por: Ballouhey, Quentin, et al.
Publicado: (2015)

A prospective multicenter study on bladder cancer: the COBLAnCE cohort
por: Benhamou, Simone, et al.
Publicado: (2016)

Pain Management in a Model of Interstitial Cystitis/Bladder Pain Syndrome by a Vaccinal Strategy
por: Augé, Céline, et al.
Publicado: (2021)

RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action
por: Masliah-Planchon, Julien, et al.
Publicado: (2015)

Assessing reproducibility of matrix factorization methods in independent transcriptomes
por: Cantini, Laura, et al.
Publicado: (2019)

Gene List significance at-a-glance with GeneValorization
por: Brancotte, Bryan, et al.
Publicado: (2011)

Correction: Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision
por: Grieco, Luca, et al.
Publicado: (2013)

Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision
por: Grieco, Luca, et al.
Publicado: (2013)

Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants
por: Villy, M.-C., et al.
Publicado: (2021)

A Naive Lung Adenocarcinoma Harboring G1269A ALK Resistance Mutation
por: Trabelsi-Grati, Olfa, et al.
Publicado: (2020)

Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives
por: Silina, Linda, et al.
Publicado: (2020)

In vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts
por: Passeri, Thibault, et al.
Publicado: (2022)

Identification of a large intra-exonic deletion in BRCA2 exon 18 in a pancreatic ductal adenocarcinoma
por: Debbabi, Inès, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9tvtjlshb9v7k8f2eh9s75tdg5